Bionano Genomics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Bionano Genomics (BNGO).

Price Target Range — 7 Quarters

Analyst Consensus — 5 Analysts

2Buy

3Hold

Consensus RatingBuy# Analysts5Avg. Consensus PT$6Upside to Avg. PT+404.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 13, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$7→$6
Nov 24, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$11→$7
Aug 18, 2025	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$10→$11
May 20, 2025	Maxim Group	Jason McCarthy	Upgrade	Hold→Buy	$8
Apr 9, 2025	HC Wainwright & Co.	Yi Chen	Initiate	Buy	$10
Apr 2, 2025	Scotiabank	Sung Ji Nam	PT Raise	Sector Perform	$1→$4
Nov 15, 2024	Ladenburg Thalmann	Jeff Cohen	Downgrade	Buy→Neutral	—
Sep 10, 2024	BTIG	Mark Massaro	Downgrade	Buy→Neutral	—
Aug 28, 2024	Scotiabank	Sung Ji Nam	Downgrade	Sector Outperform→Sector Perform	$360→$60
May 16, 2024	BTIG	Mark Massaro	PT Cut	Buy	$180→$120
Mar 7, 2024	Scotiabank	Sung Ji Nam	PT Cut	Sector Outperform	$420→$360
Nov 13, 2023	Maxim Group	Jason McCarthy	Downgrade	Buy→Hold	—

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $6

HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and lowers the price target from $7 to $6.

Benzinga Newsdesk

Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Bionano Genomics, Inc. (BNGO) will release Q4 earnings on March 23. Analysts expect $1.40 loss per share on $7.85M revenue. Stock closed at $1.12.

Avi Kapoor

Baidu To Rally More Than 69%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $7

HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and lowers the price target from $11 to $7.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Raises Price Target to $11

HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and raises the price target from $10 to $11.

Benzinga Newsdesk

PRO
Maxim Group Upgrades Bionano Genomics to Buy, Announces $8 Price Target

Maxim Group analyst Jason McCarthy upgrades Bionano Genomics (NASDAQ:BNGO) from Hold to Buy and announces $8 price target.

Benzinga Newsdesk

Bionano Genomics Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Bionano Genomics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $6

Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Baidu To Rally More Than 69%? Here Are 10 Top Analyst Forecasts For Monday

PRO
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $7

PRO
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Raises Price Target to $11

PRO
Maxim Group Upgrades Bionano Genomics to Buy, Announces $8 Price Target

People Also Watch

People Also Watch

Bionano Genomics Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Bionano Genomics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $6

Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Baidu To Rally More Than 69%? Here Are 10 Top Analyst Forecasts For Monday

PROHC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $7

PROHC Wainwright & Co. Maintains Buy on Bionano Genomics, Raises Price Target to $11

PROMaxim Group Upgrades Bionano Genomics to Buy, Announces $8 Price Target

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $6

PRO
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $7

PRO
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Raises Price Target to $11

PRO
Maxim Group Upgrades Bionano Genomics to Buy, Announces $8 Price Target